Category: Anal cancer

Home / Anal cancer

Categories

Retifanlimab-dlwr with carboplatin and paclitaxel is approved by the USFDA and as a single agent for squamous cell carcinoma of the anal canal

On May 15, 2025, the Food and Drug Administration sanctioned retifanlimab-dlwr (Zynyz, Incyte Corporation) in conjunction with carboplatin and paclitaxel for the initial treatment of people with inope...

Pembrolizumab approved for use in any cancer with a high tumor mutational burden

July 2021: The US Food and Medication Administration (FDA) has expanded the indications for pembrolizumab (Keytruda), an immunotherapy drug, to encompass any cancer with a high mutational burden (TMB-...

Eating grapes may prevent you from cancer

Some research shows eating grapes may prevent cancer. Lung malignancy is the deadliest type of tumor on the planet, and 80% of deaths are associated with smoking. Notwithstanding tobacco control, comp...

Scan the code